Bull Market for Bear Bile Leads to China IPO: Adam Minter

On Feb. 1, with little fanfare, the China Securities Regulatory Commission released a list of 217 companies seeking approval to hold initial public offerings in the coming months. It included manufacturers, property developers and, if you looked hard enough, a firm primarily engaged in the business of selling bile extracted from the gallbladders of live bears.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.